IDNA

iShares Genomics Immunology and Healthcare ETF · PSE

Category Equity
Expense Ratio 0.47%
Listing Date Jun 13, 2019
Volume 35,780.0
Market Cap (AUM) $124.52M

Performance

-3.53%

-1.65%

-9.44%

-1.24%

-0.68%

YTD

+4.3%

Top Holdings

Name
Symbol
%Assets
Moderna, Inc.MRNA6.39%
Revolution Medicines, Inc.RVMD5.60%
Sarepta Therapeutics, Inc.SRPT5.12%
Regeneron Pharmaceuticals, Inc.REGN4.75%
Merck & Co., Inc.MRK4.56%
Incyte CorporationINCY4.29%
GSK plcGSK4.15%
SanofiSAN3.75%
Roche Holding Ltd Dividend Right Cert.ROG3.72%
Exelixis, Inc.EXEL3.67%

Advanced Technical Analysis

Technical Analysis of IDNA 2024-12-20

The stock indicators reflect a predominantly bearish sentiment, with a Moving Average Score of 10 indicating strong downward pressure, while the Oscillators Score of 53 suggests a neutral stance. Overall, the Technical Score of 31 reinforces the bearish outlook, signaling caution for potential investors.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Recent News & Updates

2022-09-09 01:45
BlackRock Zeros in on Themed ETFs(Yahoo Finance)
2022-03-30 01:30
Vir Jumps 20% On S&P SmallCap 600 News(Yahoo Finance)
2022-02-25 08:59
Best Biotech ETFs for Q2 2022(Investopedia)
2021-12-05 21:15
BlackRock Releases Megatrends Report(Yahoo Finance)
2021-10-20 22:15
ETF Battles: ARKG Vs IDNA Vs GNOM(Yahoo Finance)
2020-05-18 03:42
Biotech ETFs to watch as companies push for coronavirus treatments(Yahoo Finance)
2020-05-17 22:51
Biotech ETFs trade higher on upbeat coronavirus results(Marketwatch)
2019-12-22 23:00
Will Biotech ETFs Excel in Election Year Post a Surge in 2019?(Yahoo Finance)
2019-12-18 00:41
Best & Worst Monthly Performers: December 18 Edition(Yahoo Finance)
2019-11-25 05:55
Genomics ETFs Surge on CRISPR's Gene Editing Progress(Yahoo Finance)
2019-11-20 23:56
Best & Worst Monthly Performers: November 21 Edition(Yahoo Finance)
2019-11-04 00:00
Value Biotech ETFs & Stocks to Buy Now(Yahoo Finance)
2019-10-22 22:10
Biotech ETFs Surge on a Flurry of Positive News(Yahoo Finance)
2019-09-06 03:07
ETFs Poised to Benefit from Gene Editing Revolution(Yahoo Finance)
2019-09-04 03:18
ETFs to Gain From the Booming Genomics Market(Yahoo Finance)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.